A team of researchers at the Federal University of ABC (UFABC) in Brazil has developed a new chemical compound with the potential to treat Alzheimer’s disease. The research involved computer simulations (in silico), cell culture tests (in vitro), and animal experiments (in vivo) and yielded promising results. The group is now seeking partnerships with pharmaceutical companies to conduct clinical trials.
This article was originally published on MedicalXpress.com

